2023年5月9日

分享Aetion,全球領先的技術和分析真實的證據,宣布啟動Aetion發現,一個新的應用程序進行探索性分析。應用程序為用戶提供了一個直觀的界麵生成迅速在生物製藥和醫學技術生命周期假說和見解。與Aetion證實——也建立在Aetion證據平台發現權力的結果快速、可靠和可伸縮的。開發和商業化資產、科學家、技術人員、和分析師尋求更快、更簡單的方法來理解大,縱向數據和這些數據的見解。發現,用戶可以查看、評估和選擇為他們的特定的分析目標數據集。在和整個數據集,用戶可以定義和描述感興趣的人群,並獲得任意數量的任務,和解釋結果job-critical問題,如標簽expansion-related假說的一代。相關文章的速度,包括加速隊列創建通過可定製的模板。可審核性——快速迭代和保證透明度和一致性。數據集之間的兼容性,靈活性、模型和Aetion應用程序。沒有妥協,直觀,可視化用戶體驗與可信的科學方法。 “Time and time again, we heard our customers’ interest in expanding our technology toward ‘everyday insights,’ and, importantly, for this [visual] exploration work to readily extend into advanced evidence generation when needed,” said Dr. Jeremy Rassen , Aetion president, co-founder, and chief technology officer. “We’re glad to bring our software to a wider set of use cases, to create essential insights and efficiencies across user groups. Like all Aetion offerings, Discover is based in the latest and best science and works across a wide range of real-world data.” Discover is fully compatible with Substantiate, Aetion’s application for regulatory-grade descriptive and causal analyses. Discover and Substantiate are powered by Aetion’s core technology platform — Aetion Evidence Platform.